TABLE 3.
Transconjugant | Donor strain | Transferred bla gene(s) | MICa (μg/ml)
|
Antimicrobial resistance patternb | ||||
---|---|---|---|---|---|---|---|---|
CTX | CAZ | ATM | FEP | FOX | ||||
P1-1J | 03K892 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 2 | AMP AMK GEN KAN SXT |
11-1J | 03K681 | blaCTX-M-3, blaOXA-30 | 128 | 4 | 16 | 16 | 8 | AMP AMK GEN KAN SXT |
15-1J | EC25 | blaCTX-M-3 | 64 | <1 | 16 | 8 | 2 | AMP AMK GEN KAN SXT TMP |
35-1J | KP7 | blaCTX-M-3 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT TMP |
36-1J | KP9 | blaCTX-M-3 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT TMP |
34-2J | KP2 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 2 | AMP AMK GEN KAN SXT |
34-1J | KP 2 | blaCTX-M-3, blaSHV-12, blaDHA-1 | 32 | 16 | 32 | <1 | 32 | AMP AMK GEN KAN CHL STR SXT |
24-1J | 03K839 | blaCTX-M-3, blaOXA-30, blaTEM-1 | 128 | 16 | 32 | 8 | 4 | AMP GEN KAN SXT TMP |
38-1J | 03K188 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT |
39-1J | 03K196 | blaCTX-M-3, blaOXA-30 | 64 | <1 | 8 | 4 | 4 | AMP AMK GEN KAN SXT |
40-1J | 03K201 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT |
41-1J | 03K205 | blaCTX-M-3, blaOXA-30 | 32 | 2 | 16 | 8 | 8 | AMP AMK GEN KAN SXT |
37-1J | 03K168 | blaCTX-M-3, blaOXA-30 | 32 | <1 | 2 | <1 | 4 | AMP AMK GEN KAN SXT |
43-1J | 03K921 | blaCTX-M-3 | 32 | 2 | 8 | 32 | 2 | AMP KAN STR |
44-1J | 03K980 | blaCTX-M-3 | 4 | 2 | 8 | 32 | 4 | AMP AMK KAN STR |
45-1J | SM 16 | blaCTX-M-3 | 4 | 2 | 16 | 32 | 8 | AMP AMK GEN KAN STR SXT TMP |
46-1J | SM 3 | blaCTX-M-3 | 8 | 2 | 16 | 16 | 8 | AMP AMK GEN KAN STR SXT TMP |
13-1J | 03K865 | blaCTX-M-15 | 128 | <1 | 8 | 2 | 4 | AMP |
14-1J | 03K969 | blaCTX-M-15, blaOXA-30, blaTEM-1 | 512 | 8 | 16 | 8 | 4 | AMP SXT TMP |
20-1J | J144 | blaCTX-M-15 | 256 | 8 | 16 | 8 | 4 | AMP SXT |
22-1J | J159 | blaCTX-M-15 | 128 | <1 | 4 | 8 | 32 | AMP |
19-1J | J133 | blaCTX-M-15, blaTEM-54 | 256 | 4 | 16 | 4 | 4 | AMP |
06-1J | J187 | blaCTX-M-9 | 8 | <1 | 2 | 2 | 32 | AMP CHL TET SXT TMP |
05-1J | 03K42 | blaCTX-M-9, blaSHV-12 | 4 | 4 | 8 | <1 | 2 | AMP CHL SXT TMP |
09-2J | 03K380 | blaCTX-M-9, blaSHV-12 | 8 | 64 | 64 | <1 | 2 | AMP CHL SXT TMP |
18-1J | 18-1J | blaCTX-M-14, blaOXA-30, blaTEM-1 | 512 | 2 | 8 | 16 | 4 | AMP TET STR SXT |
16-1J | EC27 | blaCTX-M-14 | 128 | 2 | 16 | 16 | 8 | AMP |
23-1J | J167 | blaCTX-M-14 | 64 | <1 | 8 | 8 | 8 | AMP STR SXT |
25-1J | 03K930 | blaCTX-M-14 | 64 | <1 | 2 | 4 | 4 | AMP STR SXT |
E. coli J53 AzideR recipient | <1 | <1 | <1 | <1 | 4 |
MIC as determined by the agar dilution method. Abbreviations: CTX, cefotaxime; CAZ, ceftazidime; ATM, aztreonam; FEP, cefepime; FOX, cefoxitin.
Abbreviations: AMP, ampicillin; CHL, chloramphenicol; TET, tetracycline; STR, streptomycin; SXT, sulfisoxazole; TMP, trimethoprim; KAN, kanamycin; GEN, gentamicin; AMK, amikacin.